NICE rejects Novartis’ migraine prevention drug AimovigSome migraine sufferers in the UK hoping to get access to Novartis’ new migraine prevention drug Aimovig are Share XNICE rejects Novartis’ migraine prevention drug Aimovighttps://pharmaphorum.com/news/nice-rejects-novartis-migraine-prevention-drug-aimovig/
Breakthrough migraine prevention treatment approved in EuropeNovartis’ Aimovig (erenumab) has been approved by the European Medicines Agency (EMA) making it first self-administered, monthly migraine Share XBreakthrough migraine prevention treatment approved in Europehttps://pharmaphorum.com/news/breakthrough-migraine-prevention-treatment-approved-in-europe/
Migraine prevention drug Aimovig poised for EU approvalThe first antibody treatment to prevent migraine (Aimovig), produced by Novartis, is on the cusp of approval. The Share XMigraine prevention drug Aimovig poised for EU approvalhttps://pharmaphorum.com/news/migraine-prevention-aimovig-eu-approval/
